Navigation Links
New Web Sites Educate About Triglycerides and HDL Cholesterol

ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Nearly one in three adult Americans have triglyceride (trig) levels that are above normal and nearly 34 million have low HDL "good" cholesterol levels. To help increase awareness about the importance of HDL and trigs, Abbott has launched two Web sites: and

"Unhealthy high triglyceride and low HDL levels are factors that can raise the risk of heart disease," said Eliot A. Brinton, M.D., associate professor, University of Utah, School of Medicine. "Understanding cholesterol and lipids, fats found in the blood, can be confusing, but it's important patients know what HDL and triglycerides are and how they can affect heart health."

Often, cholesterol conversations center on LDL, the "bad" cholesterol. These Web sites focus on commonly overlooked HDL and trigs and the role they play in health. Other information featured includes tips on diet, exercise and how patients can talk to their doctor about their risk factors for heart disease.

"Abbott has a long-standing commitment to patient education and providing tools patients need to take a proactive approach to managing their health," said Darryl Sleep, M.D., Dyslipidemia project director, Abbott. "These new Web sites encourage education, a healthy lifestyle and communication with physicians to help patients better understand important heart disease risk factors."

About HDL Cholesterol

There are two sources of HDL cholesterol: the liver and food. According to the American Heart Association, a low level of HDL cholesterol (less than 40 mg/dL for men and less than 50 mg/dL for women) may increase the risk of developing heart disease. However, a high level of HDL cholesterol (60 mg/dL or more) may protect against heart disease.

About Triglycerides

Triglycerides are lipids, fats found in the blood, made by the body and found in food. In normal amounts (less than 150 mg/dL), triglycerides help provide energy and are important to one's health. However, high amounts of triglycerides (200 mg/dL or more) can contribute to the hardening and narrowing of blood vessels, making it hard for blood to flow and increasing the risk for heart disease.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 72,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at


Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
3. Alseres Pharmaceuticals Expands Sites for the First Stage of the ALTROPANE(R) Phase III Clinical Trial Program
4. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
5. Velos Set to Clear 50 Percent Market Penetration of Large U.S. Clinical Research Sites by Year End
6. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
7. Parasites That Live Inside Cells Use Loophole to Thwart Immune System
8. CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial
9. CVBT Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial
10. Radius Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
11. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
Post Your Comments:
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
(Date:11/25/2015)... WASHINGTON , Nov. 25, 2015  The ... Obstetricians and Gynecologists (ACOG), and the March of ... bipartisan Protecting Our Infants Act of 2015 ... the number of newborns born exposed to drugs, ... Since the bill,s introduction, all three organizations have ...
(Date:11/25/2015)...  Linden Care, LLC, a retail specialty pharmacy focused ... suffering from chronic pain, said today that it is ... (TRO) enjoining Express Scripts from unilaterally terminating the Pharmacy ... --> --> The company said that ... --> --> In ...
Breaking Medicine Technology:
(Date:11/25/2015)... Cokato, MN (PRWEB) , ... November 25, 2015 , ... ... Thanksgiving through Christmas Eve on several models of traditional and far-infrared saunas. ... . Nordic Spruce is the most traditional Finnish sauna wood, and Finnleo uses only ...
(Date:11/25/2015)... ... November 25, 2015 , ... Medical Solutions, ... again for its stellar workplace culture with the company’s Cincinnati office being named ... Solutions’ Cincinnati office was named a finalist in Cincinnati Business Courier’s 13th annual ...
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... Dr. John ... to learn more about hair loss treatment with the Capillus272™ Pro laser therapy cap. ... solution for thicker and fuller hair, without the need for surgery, prescription pills, or ...
(Date:11/25/2015)... ... November 26, 2015 , ... Ministers, senior government and UN ... African Centres of Excellence, and public R&D institutions, civil societies and other partners ... the 5th African Network for Drugs and Diagnostics Innovation, ANDI, Stakeholders Meeting. The ...
Breaking Medicine News(10 mins):